![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Phosphatases Disease Areas: Cancer Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
Target Class: Non-protein Kinase Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Follow-up not counted |
||
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Phosphoinosotide dependent signalling Disease Areas: Signalling Site: Stockholm Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Cancer Site: Stockholm Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Phosphatases Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: Protein Kinase Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling, Neurobiology Site: Oxford Status: Official |
||
Target Class: G-Protein Regulators Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Oxford Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Signalling proteins Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
Human farnesyl diphosphate synthase in complex with zoledronate, isopentenyl pyrophosphate and magne Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology, Cancer Site: Oxford Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Neurobiology Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Signalling, Cancer, Drug metabolism and toxicology Site: Oxford Status: Official |
||
Target Class: G-Protein Regulators Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Signalling proteins Disease Areas: Cancer, Neurobiology, Metabolism, Signalling Site: Oxford Status: Official |
||
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Proteases Disease Areas: Signalling, Cancer Site: Toronto Status: Official |
||
Target Class: Signalling proteins Disease Areas: Signalling, Cancer, Neurobiology Site: Oxford Status: Official |
||
Target Class: Transferases Disease Areas: Cancer, Metabolism Site: Toronto Status: Official |
||
Target Class: Phosphatases Disease Areas: Signalling, Neurobiology Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Neurobiology, Drug metabolism and toxicology Site: Oxford Status: Official |
||
Target Class: Non-protein Kinase Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism Site: Toronto Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Isomerases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Metabolism, Drug metabolism and toxicology, Cancer Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Signalling, Neurobiology, Metabolism Site: Oxford Status: Official |
||
Target Class: Non-protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Neurobiology, Metabolism, Drug metabolism and toxicology Site: Oxford Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Protein Kinase Disease Areas: Signalling Site: Oxford Status: Official |
||
Target Class: Transferases Disease Areas: Signalling, Chromatin and epigenetics Site: Toronto Status: Official |
||
Target Class: GTPases Disease Areas: Neurobiology, Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism Site: Oxford Status: Official |
||
Target Class: GTPases Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer Site: Oxford Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Transferases Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Protein Kinase Disease Areas: Signalling, Cancer Site: Oxford Status: Follow-up not counted |
||
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: Phosphatases Disease Areas: Neurobiology, Signalling Site: Oxford Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Neurobiology Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Cancer Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Drug metabolism and toxicology, Metabolism Site: Oxford Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Signalling Site: Oxford Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E2 Conjugate Enzymes Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Signalling, Metabolism Site: Oxford Status: Official |
||
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Official |
||
Target Class: Transferases Disease Areas: Cancer, Drug metabolism and toxicology, Metabolism Site: Toronto Status: Official |
||
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Malaria Disease Areas: Parasitic disease Site: Toronto Status: Official |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Official |
||